| Literature DB >> 35492614 |
Xiaolu Xi1, Jincheng Liu1, Hao Sun1, Ke Xu1, Xue Wang1, Liyuan Zhang1, Tianming Du1, Jian Liu2, Bao Li1.
Abstract
Background: The conventional FFRct numerical calculation method uses a model with a multi-scale geometry based upon CFD, and rigid walls. Therefore, important interactions between the elastic vessel wall and blood flow are not routinely considered. Changes in the resistance of coronary microcirculation during hyperaemia are likewise not typically incorporated using a fluid-structure interaction (FSI) algorithm. It is likely that both have resulted in FFRct calculation errors. Objective: In this study we incorporated both the influence of vascular elasticity and coronary microcirculatory structure on FFR, to improve the accuracy of FFRct calculation. Thus, in this study, a physics-driven 3D-0D coupled model including fluid-structure interaction was established to calculate accurate FFRct values.Entities:
Keywords: 0D/3D geometric multi-scale model; coronary artery; fluid-structure interaction; fractional flow reserve; hemodynamic effects
Year: 2022 PMID: 35492614 PMCID: PMC9039540 DOI: 10.3389/fphys.2022.861446
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Dual-coupled coronary model with 70% stenosis and 10 mm stenosis length.
Hemodynamic parameters and equivalent electrical parameters.
| Hemodynamic parameter | Blood flow | Blood pressure | Microcirculation resistance | Vascular elasticity | Blood flow inertia |
|---|---|---|---|---|---|
| Equivalent electrical parameter | Current | Voltage | Electrical resistance | Capacitance | Inductance |
FIGURE 2Data transfer between fluid and solid domains. (CFD: computational fluid dynamics; CSM: computational structural mechanics).
FIGURE 3Flow chart of dual-coupled model algorithm.
FIGURE 4Changes in microcirculation resistance due to hyperemia.
Basic information describing the 15 enrolled patients. Values shown are either counts or mean values (with standard deviations in parentheses, where available).
|
|
|
|---|---|
| Number of patients | 15 |
| Number of vessels | 15 |
| Ages | 64( ± 8.95) |
| Number of males | 10 |
| Number of females | 5 |
| Number of left artery descending (LAD) | 10 |
| Number of right coronary artery (RCA) | 5 |
| Systolic blood pressure/mmHg | 140( ± 17.99) |
| Diastolic blood pressure/mmHg | 79( ± 9.01) |
| Left ventricular systolic volume/mm3 | 31.3( ± 4.3) |
| Left ventricular diastolic volume/mm3 | 101.84( ± 7.2) |
| Heart rate/bpm | 60.42( ± 8.38) |
| Cardiac output/(L·min-1) | 4.251( ± 2.18) |
| Myocardial mass/g | 141.7( ± 23.72) |
FIGURE 5FFRct Pressure cloud image calculated based on dual models. (A) Pressure cloud of patient 2 for both computational models. (B) Pressure cloud of patient 4 for both computational models. (C) Pressure cloud of patient 6 for both computational models. (D) Pressure cloud of patient 5 for both computational models.
The calculated and measured FFR results for all of the 15 patients.
| Patient | Clinically | FFRDC | FFRCFD | Rm | Computation time (FFRDC/FFRCFD) [h] |
|---|---|---|---|---|---|
| [mmHg s/ml] | |||||
| 1 | 0.76 | 0.77 | 0.8 | 132.99 | 18/3 |
| 2 | 0.98 | 0.93 | 0.86 | 81.72 | 9/4.5 |
| 3 | 0.91 | 0.91 | 0.88 | 142.26 | 10.1/4 |
| 4 | 0.89 | 0.88 | 0.85 | 133.42 | 12.5/3 |
| 5 | 0.93 | 0.92 | 0.89 | 146.62 | 10.7/5 |
| 6 | 0.91 | 0.91 | 0.88 | 83.49 | 11.2/2 |
| 7 | 0.97 | 0.91 | 0.89 | 82.05 | 8.6/3.3 |
| 8 | 0.89 | 0.85 | 0.79 | 109.27 | 11.7/4 |
| 9 | 0.75 | 0.71 | 0.67 | 124.17 | 18.2/3.3 |
| 10 | 0.91 | 0.91 | 0.9 | 427.34 | 9.5/3 |
| 11 | 0.71 | 0.81 | 0.78 | 143.22 | 20.4/8 |
| 12 | 0.98 | 0.95 | 0.9 | 95.11 | 9.1/4 |
| 13 | 0.84 | 0.83 | 0.76 | 101.35 | 13.7/4 |
| 14 | 0.84 | 0.78 | 0.74 | 105.87 | 14.6/3.5 |
| 15 | 0.89 | 0.85 | 0.83 | 129.76 | 12.2/4.3 |
FIGURE 6Comparison between clinically measured FFR and FFRct calculated with different models.
FIGURE 7Analysis of clinical FFR data, FFRDC and FFRCFD. (A) BlandAltman plots for the pairwise comparisons of clinical FFR data and FFRDC. (B) BlandAltman plots for the pairwise comparisons of clinical FFR data and FFRCFD. (C) A comparison of clinical FFR data and FFRDC. (D) A comparison of clinical FFR data and FFRCFD. (E) ROC analysis of FFRDC and FFRCFD, using clinical FFR data as a reference.